Usability and Clinical effectiveness of the NEVERMIND system
SND-ID: 2023-106-1. Version: 1. DOI: https://doi.org/10.48723/21y0-2g17
Associated documentation
Citation
Creator/Principal investigator(s)
Nuhamin Gebrewold Petros
- Karolinska Institutet
Research principal
Karolinska Institutet
- Department of Learning, Informatics, Management and Ethics
Description
The data provided is from the NEVERMIND trial, a randomized controlled trial to assess the effectiveness of the NEVERMIND system in reducing depressive symptoms among individuals with severe somatic conditions. The dataset includes data on 255 patients diagnosed with breast cancer or prostate cancer who were randomly assigned to the NEVERMIND intervention or a control group. The data includes baseline sociodemographic data, structured questionnaires on mental health symptoms (Beck Depression Inventory-II and Depression, Anxiety and Stress Scale-21), acceptability and usability (System Usability Scale, user version of the Mobile Application Rating Scale, Perceived usefulness and Perceived ease of use) and recorded log data collected at 12 weeks to assess the effectiveness, usability, and acceptability of the NEVERMIND system.
The NEVERMIND system consists of a shirt and a smart phone. Sensors in the shirt and an application in the smart phone data collect data on the patient's condition.
The main purpose of the dataset is to investigate the relationship between the clinical effectiveness, us
The NEVERMIND system consists of a shirt and a smart phone. Sensors in the shirt and an application in the smart phone data collect data on the patient's condition.
The main purpose of the dataset is to investigate the relationship between the clinical effectiveness, usability, and acceptability of the NEVERMIND eHealth intervention for treating depressive and stress symptoms in breast and prostate cancer patients. Linear mixed model analyses and multiple regression were used to evaluate the association between clinical effectiveness, usability, and acceptability variables.
The dataset is relevant for reuse by researchers interested in investigating the effectiveness of eHealth interventions for treating depressive and stress symptoms in cancer patients.
The dataset consists of a file called dataset_usability_clinical_nevermind.xlsx, which contains a table with data collected from individuals in the study. A codebook file (Codebook.xlsx) is also included and defines the variables used in the table. Show less..
Data contains personal data
Yes
Sensitive personal data
Yes
Type of personal data
Residence, Age, Sex, Marital Status, Employment, Cancer Diagnosis
Code key exists
Yes
Language
Unit of analysis
Population
255 patients diagnosed either with stage II, III, or IV breast or prostate cancer were randomly assigned to the NEVERMIND intervention or a control group.
Time Method
Study design
Randomised controlled trial (RCT)
Description of study design
The study uses data from the NEVERMIND trial which is a parallel-groups, pragmatic randomised controlled trial to assess the effectiveness of the NEVERMIND system in reducing depressive symptoms among individuals with severe somatic conditions. The trial started in November 2016 and ended in June 2020. Enrollment of participants began December 2017 and last data collected was conducted in June 2020. The main RCT includes patients who have a diagnosis of myocardial infarction, breast cancer, prostate cancer, kidney failure, or lower limb amputation, but this data document only includes breast and prostate cancer patients. Participants were randomised in blocks of ten to either the NEVERMIND intervention or treatment as usual as the control group. Clinical interviews and structured questionnaires are administered at baseline, and at 12 weeks to assess whether the NEVERMIND system is superior to treatment as usual.
Sampling procedure
Time period(s) investigated
2016-11 – 2020-06
Variables
27
Number of individuals/objects
255
Data format / data structure
Geographic spread
Geographic location: Italy, Western Europe
Geographic description: Data was recruited from patients in Turin, Italy.
Responsible department/unit
Department of Learning, Informatics, Management and Ethics
Ethics Review
Swedish Ethical Review Authority - Ref. 2020-04175
Research area
Medical and health sciences (Standard för svensk indelning av forskningsämnen 2011)
Public health, global health, social medicine and epidemiology (Standard för svensk indelning av forskningsämnen 2011)
Keywords
Petros, N., Hadlaczky, G., Carletto, S., Martinez, S., Ostacoli, L., Ottaviano, M., Meyer, B., Scilingo, E., & Carli, V. (n.d.). Sociodemographic Characteristics Associated With an eHealth System Designed to Reduce Depressive Symptoms Among Patients With Breast or Prostate Cancer: Prospective Study. In JMIR formative research (Vol. 6, Issue 6, pp. e33734-). https://doi.org/10.2196/33734
DOI:
https://doi.org/10.2196/33734
SwePub:
oai:prod.swepub.kib.ki.se:235675116
Carli, V., Petros, N., Hadlaczky, G., Vitcheva, T., Berchialla, P., Bianchi, S., Carletto, S., Christinaki, E., Citi, L., Dinis, S., Gentili, C., Geraldes, V., Giovinazzo, L., Gonzalez-Martinez, S., Meyer, B., Ostacoli, L., Ottaviano, M., Ouakinin, S., Papastylianou, T., … Valenza, G. (2022). The NEVERMIND e-health system in the treatment of depressive symptoms among patients with severe somatic conditions: A multicentre, pragmatic randomised controlled trial. In EClinicalMedicine (Vol. 48, pp. 101423-). https://doi.org/10.1016/j.eclinm.2022.101423
DOI:
https://doi.org/10.1016/j.eclinm.2022.101423
SwePub:
oai:prod.swepub.kib.ki.se:150119517
Carli, V., Wasserman, D., Hadlaczky, G., Petros, N. G., Carletto, S., Citi, L., ... & Scilingo, E. P. (2020). A protocol for a multicentre, parallel-group, pragmatic randomised controlled trial to evaluate the NEVERMIND system in preventing and treating depression in patients with severe somatic conditions. BMC psychiatry, 20(1), 1-10.
DOI:
https://doi.org/10.1186/s12888-020-02494-3
